Literature DB >> 17916791

A novel approach for ganglioside structural analysis based on electrospray multiple-stage mass spectrometry.

Alina D Zamfir1, Zeljka Vukelic, Andrea Schneider, Eugen Sisu, Nicolae Dinca, Arnd Ingendoh.   

Abstract

A powerful method for detailed structural analysis based on electrospray ionization high-capacity ion-trap multiple-stage mass spectrometry (MS) is for the first time introduced in glycolipidomics. The method was optimized for accurate structural elucidation of human brain gangliosides and specifically applied to normal adult human hippocampus-associated structures. The multiple-stage MS experiments reported here allowed for a complete structural characterization of the oligosaccharide moiety of a GM1 ganglioside species. This was achieved by elucidating the sequence and identification of the GM1a structural isomer from the sialic acid attachment site at the neutral oligosaccharide chain. Moreover, the determination of the d18:1/18:0 sphingoid base/fatty acid composition of the ceramide moiety could be confirmed by this method. The novel protocol developed here proves high potential for rapid, reliable, and reproducible investigation of complex lipid-linked carbohydrates such as polysialylated gangliosides or species carrying some other groups that easily cleave off.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916791      PMCID: PMC2062554     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  40 in total

Review 1.  Developmental expression and possible roles of gangliosides in brain development.

Authors:  H Rösner
Journal:  Prog Mol Subcell Biol       Date:  2003

Review 2.  Gangliosides and neuronal-astrocytic interactions.

Authors:  R K Yu; M Saito
Journal:  Prog Brain Res       Date:  1992       Impact factor: 2.453

Review 3.  New mass spectral approaches to ganglioside structure determinations.

Authors:  C E Costello; P Juhasz; H Perreault
Journal:  Prog Brain Res       Date:  1994       Impact factor: 2.453

4.  Gangliosides in human fetal brain.

Authors:  L Svennerholm; B M Rynmark; G Vilbergsson; P Fredman; J Gottfries; J E Månsson; A Percy
Journal:  J Neurochem       Date:  1991-05       Impact factor: 5.372

Review 5.  Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization.

Authors:  Senitiroh Hakomori
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

6.  Gangliosides in the human brain development and aging.

Authors:  I Kracun; H Rosner; V Drnovsek; Z Vukelic; C Cosovic; M Trbojevic-Cepe; M Kubat
Journal:  Neurochem Int       Date:  1992-04       Impact factor: 3.921

7.  Cortical distribution of gangliosides in Alzheimer's disease.

Authors:  I Kracun; S Kalanj; J Talan-Hranilovic; C Cosovic
Journal:  Neurochem Int       Date:  1992-04       Impact factor: 3.921

Review 8.  Glycolipid-mediated cell-cell recognition in inflammation and nerve regeneration.

Authors:  Ronald L Schnaar
Journal:  Arch Biochem Biophys       Date:  2004-06-15       Impact factor: 4.013

Review 9.  Ganglioside function in the development and repair of the nervous system. From basic science to clinical application.

Authors:  S D Skaper; A Leon; G Toffano
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

10.  On-line sheathless capillary electrophoresis/nanoelectrospray ionization-tandem mass spectrometry for the analysis of glycosaminoglycan oligosaccharides.

Authors:  Alina Zamfir; Daniela G Seidler; Elke Schönherr; Hans Kresse; Jasna Peter-Katalinic
Journal:  Electrophoresis       Date:  2004-07       Impact factor: 3.595

View more
  2 in total

1.  Scientific literature addressing detection of monosialoganglioside: A 10-year bibliometric analysis.

Authors:  Yanli Xu; Miaojing Li; Zhijun Liu; Aiping Xi; Chaoxian Zhao; Jianzhong Zhang
Journal:  Neural Regen Res       Date:  2012-04-05       Impact factor: 5.135

2.  Lipidomics of glycosphingolipids.

Authors:  Hany Farwanah; Thomas Kolter
Journal:  Metabolites       Date:  2012-02-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.